ACRS - Aclaris Therapeutics Stock Trading

Aclaris Therapeutics Inc.(NASDAQ: ACRS) stock trading, description, contact, officers and directors.

About Aclaris Therapeutics Inc.

Aclaris Therapeutics, Inc. is a clinical stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in dermatology

Stock Information

Aclaris Therapeutics Inc. Company Name:

ACRS Stock Symbol:

NASDAQ Market:

Aclaris Therapeutics Inc. Website:

ACRS - Aclaris Therapeutics Stock Trading

ACRS ACRS Quote ACRS Short ACRS News ACRS Articles ACRS Message Board

Get ACRS Alerts

News, Short Squeeze, Breakout and More Instantly...

ACRS - Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action

WAYNE, Pa., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that a settlement hearing (the “Settlement Hearing”...
ACRS - Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Public Offering with Net Proceeds of $134.9 Million in June Strengthens Balance Sheet and Extends Cash Runway Through the End of 2024 Positive Preliminary Topline Data for Phase 2a Trial of ATI-1777 in Moderate to Severe Atopic Dermatitis Announced in June Adva...
ACRS - Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021

WAYNE, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will particip...